Company / Operating Cash Flow
HERON THERAPEUTICS, INC. /DE/ Operating Cash Flow History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$78.5M
FY2017
5-year range
-$78.5M / -$60.3M
FY2016-FY2017
Trend
-30.3%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-$79M in FY2017.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, operating cash flow decreased 30.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | -$78.5M | -30.3% |
| FY2016 | -$60.3M | - |
As of FY2017 · SEC 10-K · Updated Jun 24, 2026